Clinical Trial Update: Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for the Wiskott-Aldrich Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 pilot and feasibility study of hematopoietic stem cell gene transfer for Wiskott-Aldrich Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wiskott-aldrich Syndrome

Drugs mentioned

• Hematopoietic stem cell gene transfer

Snippet

Sponsor: David Williams | Conditions: Wiskott-Aldrich Syndrome | Phase 1, Phase 2 | Status: COMPLETED